Abstract
In the mammalian nervous system, P2 nucleotide receptors mediate neurotransmission, release of proinflammatory cytokines, and reactive astrogliosis. Extracellular nucleotides activate multiple P2 receptors in neurons and glial cells, including G protein-coupled P2Y receptors and P2X receptors, which are ligand-gated ion channels. In glial cells, the P2Y2 receptor subtype, distinguished by its ability to be equipotently activated by ATP and UTP, is coupled to pro-inflammatory signaling pathways. In situ hybridization studies with rodent brain slices indicate that P2Y2 receptors are expressed primarily in the hippocampus and cerebellum. Astrocytes express several P2 receptor subtypes, including P2Y2 receptors whose activation stimulates cell proliferation and migration. P2Y2 receptors, via an RGD (Arg-Gly-Asp) motif in their first extracellular loop, bind to αvβ3/β5 integrins, whereupon P2Y2 receptor activation stimulates integrin signaling pathways that regulate cytoskeletal reorganization and cell motility. The C-terminus of the P2Y2 receptor contains two Src-homology-3 (SH3)-binding domains that upon receptor activation, promote association with Src and transactivation of growth factor receptors. Together, our results indicate that P2Y2 receptors complex with both integrins and growth factor receptors to activate multiple signaling pathways. Thus, P2Y2 receptors present novel targets to control reactive astrogliosis in neurodegenerative diseases.
Similar content being viewed by others
References
Gahtan E. and Overmier J.B. (1999) Inflammatory pathogenesis in Alzheimer’s disease: biological mechanisms and cognitive sequeli. Neurosci. Biobehav. Rev. 23(5), 615–633.
Rutka J.T., Murakami M., Dirks P.B., et al. (1997) Role of glial filaments in cells and tumors of glial origin: a review. J. Neurosurg. 87(3), 420–430.
Gendron F.P., Newbold N.L., Vivas-Mejia P.E., et al. (2003) Signal transduction pathways for P2Y2 and P2X7 nucleotide receptors that mediate neuroinflammatory responses in astrocytes and microglial cells. Biomed. Res. 14, 47–61.
Franke H., Kittner H., Grosche J., and Illes P. (2003) Enhanced P2Y1 receptor expression in the brain after sensitisation with d-amphetamine. Psychopharmacology (Berl.) 167, 187–194.
Weisman G.A., Garrad R.C., Erb L.J., Santos-Berrios C., and Gonzalez F.A. (1999) P2Y receptors in the nervous system: molecular studies of a P2Y2 receptor subtype from NG108-15 neuroblastoma x glioma hybrid cells. Prog. Brain Res. 120, 33–43.
Burnstock G. (1972) Purinergic nerves. Pharmacol. Rev. 24(3), 509–581.
Burnstock G., Campbell G., Satchell D., and Smythe A. (1970) Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br. J. Pharmacol. 40(4), 668–688.
Burnstock G. and Wood J.N. (1996) Purinergic receptors: their role in nociception and primary afferent neurotransmission. Curr. Opin. Neurobiol. 6(4), 526–532.
Neary J.T., Rathbone M.P., Cattabeni F., Abbracchio M.P., and Burnstock G. (1996) Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci. 19(1), 13–18.
Vitolo O.V., Ciotti M.T., Galli C., Borsello T., and Calissano P. (1998) Adenosine and ADP prevent apoptosis in cultured rat cerebellar granule cells. Brain Res. 809(2), 297–301.
Ostrom R.S., Gregorian C., Drenan R.M., Gabot K., Rana B.K., and Insel P.A. (2001) Key role for constitutive cyclooxygenase-2 of MDCK cells in basal signaling and response to released ATP. Am. J. Physiol. Cell Physiol. 281(2), C524-C531.
Ahmed S.M., Rzigalinski B.A., Willoughby K.A., Sitterding H.A., and Ellis E.F. (2000) Stretch-induced injury alters mitochondrial membrane potential and cellular ATP in cultured astrocytes and neurons. J. Neurochem. 74(5), 1951–1960.
Ciccarelli R., Di Iorio P., Giuliani P., et al. (1999) Rat cultured astrocytes release guanine-based purines in basal conditions and after hypoxia/hypoglycemia. Glia 25, 93–98.
Bergfeld G.R. and Forrester T. (1992) Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc. Res. 26(1), 40–47.
Bodin P. and Burnstock G. (2001) Purinergic signalling: ATP release. Neurochem. Res. 26, 959–969.
Pedersen S.F., Nilius B., Lambert I.H., and Hoffmann E.K. (1999) Mechanical stress induces release of ATP from Ehrlich ascites tumor cells. Biochim. Biophys. Acta 1416, 271–284.
Sak K. and Webb T.E. (2002) A retrospective of recombinant P2Y receptor subtypes and their pharmacology. Arch. Biochem. Biophys. 397(1), 131–136.
Inbe H. Watanabe S., Miyawaki M., Tanabe E., and Encinas J.A. (2004) Identification and characterization of a cell-surface receptor, P2Y15, for AMP and adenosine. J. Biol. Chem. 279(19), 19,790–19,799.
Burnstock G. (2000) P2X receptors in sensory neurones. Br. J. Anaesth. 84(4), 476–488.
Ciccarelli R., Ballerini P., Sabatino G., et al. (2001) Involvement of astrocytes in purine-mediated reparative processes in the brain. Int. J. Dev. Neurosci. 19, 395–414.
O’Callaghan J.P. and Jensen K.F. (1992) Enhanced expression of glial fibrillary acidic protein and the cupric silver degeneration reaction can be used as sensitive and early indicators of neurotoxicity. Neurotoxicology 13(1), 113–122.
Menet V., Prieto M., Privat A., and Gimenez y Ribotta M. (2003) Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes. Proc. Natl. Acad. Sci. USA 100(15), 8999–9004.
Eddleston M. and Mucke L. (1993) Molecular profile of reactive astrocytesimplications for their role in neurologic disease. Neuroscience 54(1), 15–36.
Norton W.T., Aquino D.A., Hozumi I., Chiu F.C., and Brosnan C.F. (1992) Quantitative aspects of reactive gliosis: a review. Neurochem. Res. 17(9), 877–885.
Mcgraw J., Hiebert G.W., and Steeves J.D. (2001) Modulating astrogliosis after neurotrauma. J. Neurosci. Res. 63(2), 109–115.
Neary J.T., Baker L., Jorgensen S.L., and Norenberg M.D. (1994) Extracellular ATP induces stellation and increases glial fibrillary acidic protein content and DNA synthesis in primary astrocyte cultures. Acta Neuropathol. (Berl.) 87(1), 8–13.
Brambilla R. and Abbracchio M.P. (2001) Modulation of cyclooxygenase-2 and brain reactive astrogliosis by purinergic P2 receptors. Ann. NY Acad. Sci. 939, 54–62.
Brambilla R., Burnstock G., Bonazzi A., Ceruti S., Cattabeni F., and Abbracchio M.P. (1999) Cyclo-oxygenase-2 mediates P2Y receptor-induced reactive astrogliosis. Br. J. Pharmacol. 126(3), 563–567.
Brambilla R., Neary J.T., Cattabeni F., et al. (2002) Induction of COX-2 and reactive gliosis by P2Y receptors in rat cortical astrocytes is dependent on ERK1/2 but independent of calcium signalling. J. Neurochem. 83(6), 1285–1296.
Franke H., Krugel U., Schmidt R., Grosche J., Reichenbach A., and Illes P. (2001) P2 receptor-types involved in astrogliosis in vivo. Br. J. Pharmacol. 134, 1180–1189.
Franke H., Krugel U., and Illes P. (1999) P2 receptor-mediated proliferative effects on astrocytes in vivo. Glia 28(3), 190–200.
Neary J.T., Whittemore S.R., Zhu Q., and Norenberg M.D. (1994) Synergistic activation of DNA synthesis in astrocytes by fibroblast growth factors and extracellular ATP. J. Neurochem. 63(2), 490–494.
Lenz G., Gottfried C., Luo Z., et al. (2000) P2Y purinoceptor subtypes recruit different mek activators in astrocytes. Br. J. Pharmacol. 129(5), 927–936.
Jacques-Silva M.C., Rodnight R., Lenz G., et al. (2004) P2X7 receptors stimulate AKT phosphorylation in astrocytes. Br. J. Pharmacol. 141(7), 1106–1117.
Fumagalli M., Brambilla R., D’Ambrosi N., et al. (2003) Nucleotide-mediated calcium signaling in rat cortical astrocytes: role of P2X and P2Y receptors. Glia 43, 218–230.
Kukley M., Barden J.A., Steinhauser C., and Jabs R. (2001) Distribution of P2X receptors on astrocytes in juvenile rat hippocampus. Glia 36(1), 11–21.
Khakh B.S., Smith W.B., Chiu C.S., Ju D., Davidson N., and Lester H.A. (2001) Activation-dependent changes in receptor distribution and dendritic morphology in hippocampal neurons expressing P2X2-green fluorescent protein receptors. Proc. Natl. Acad. Sci. USA 98(9), 5288–5293.
King B.F., Neary J.T., Zhu Q., Wang S., Norenberg M.D., and Burnstock G. (1996) P2 purinoceptors in rat cortical astrocytes: expression, calcium-imaging and signalling studies. Neuroscience 74(4), 1187–1196.
Scemes E., Duval N., and Meda P. (2003) Reduced expression of P2Y1 receptors in connexin43-null mice alters calcium signaling and migration of neural progenitor cells. J. Neurosci. 23(36), 11,444–11,452.
Chen W.C. and Chen C.C. (1998) ATP-induced arachidonic acid release in cultured astrocytes is mediated by Gi protein coupled P2Y1 and P2Y2 receptors. Glia 22(4), 360–370.
Kim S.G., Soltysiak K.A., Gao Z.G., Chang T.S., Chung E., and Jacobson K.A. (2003) Tumor necrosis factor alpha-induced apoptosis in astrocytes is prevented by the activation of P2Y6, but not P2Y4 nucleotide receptors. Biochem. Pharmacol. 65(6), 923–931.
Moore D.J., Murdock P.R., Watson J.M., et al. (2003) GPR105, a novel Gi/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: possible role in neuroimmune function. Brain Res. Mol. Brain Res. 118(1–2), 10–23.
Lustig K.D., Erb L., Landis D.M., et al. (1992) Mechanisms by which extracellular ATP and UTP stimulate the release of prostacyclin from bovine pulmonary artery endothelial cells. Biochim. Biophys. Acta 1134(1), 61–72.
Seye C.I., Kong Q., Erb L., et al. (2002) Functional P2Y2 nucleotide receptors mediate uridine 5′-triphosphate-induced intimal hyperplasia in collared rabbit carotid arteries. Circulation 106(21), 2720–2726.
Pillois X., Chaulet H., Belloc I., Dupuch F., Desgranges C., and Gadeau A.P. (2002) Nucleotide receptors involved in UTP-induced rat arterial smooth muscle cell migration. Circ. Res. 90(6), 678–681.
Kunapuli S.P. and Daniel J.L. (1998) P2 receptor subtypes in the cardiovascular system. Biochem. J. 336(3), 513–523.
Kim K.C., Park H.R., Shin C.Y., Akiyama T., and Ko K.H. (1996) Nucleotide-induced mucin release from primary hamster tracheal surface epithelial cells involves the P2u purinoceptor. Eur. Respir. J. 9(7), 1579.
Berti-Mattera L.N., Wilkins P.L., Madhun Z., and Suchovsky D. (1996) P2-purigenic receptors regulate phospholipase C and adenylate cyclase activities in immortalized Schwann cells. Biochem. J. 314(2), 555–561.
Ho C., Hicks J., and Salter M.W. (1995) A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat. Br. J. Pharmacol. 116(7), 2909–2918.
Kirishuk S., Scherer J., Kettenmann H., and Verkhratsky A. (1995) Activation of P2-purinoreceptors triggered Ca2+ release from InsP3-sensitive internal stores in mammalian oligodendrocytes. J. Physiol. 483(1), 41–57.
Miyagi Y., Kobayashi S., Ahmed A., Nishimura J., Fukui M., and Kanaide H. (1996) P2U purinergic activation leads to the cell cycle progression from the G1 to the S and M phases but not from the G0 to G1 phase in vascular smooth muscle cells in primary culture. Biochem. Biophys. Res. Commun. 222(2), 652–658.
Muscella A., Elia M.G., Greco S., Storelli C., and Marsigliante S. (2003) Activation of P2Y2 receptor induces c-FOS protein through a pathway involving mitogen-activated protein kinases and phosphoinositide 3-kinases in HeLa cells. J. Cell. Physiol. 195(2), 234–240.
Seye C.I., Yu N., Jain R., et al. (2003) The P2Y2 nucleotide receptor mediates UTP-induced vascular cell adhesion molecule-1 expression in coronary artery endothelial cells. J. Biol. Chem. 278(27), 24,960–24,965.
Koshiba M., Apasov S., Sverdlov V., et al. (1997) Transient up-regulation of P2Y2 nucleotide receptor mRNA expression is an immediate early gene response in activated thymocytes. Proc. Natl. Acad. Sci. USA 94(3), 831–836.
Turner J.T., Weisman G.A., and Camden J.M. (1997) Upregulation of P2Y2 nucleotide receptors in rat salivary gland cells during short-term culture. Am. J. Physiol. 273(3), C1100-C1107.
Xu J., Chalimoniuk M., Shu Y., et al. (2003) Prostaglandin E2 production in astrocytes: regulation by cytokines, extracellular ATP, and oxidative agents. Prostaglandins Leukotriene Essent. Fatty Acids 69(6), 437–448.
Xu J., Weng Y.I., Simonyi A., et al. (2002) Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachidonic acid release in primary murine astrocytes. J. Neurochem. 83(2), 259–270.
Welch B.D., Carlson N.G., Shi H., Myatt L., and Kishore B.K. (2003) P2Y2 receptor-stimulated release of prostaglandin E2 by rat inner medullary collecting duct preparations. Am. J. Physiol. Renal Physiol. 285(4), F711-F721.
Mohaupt M.G., Fischer T., Schwobel J., Sterzel R.B., and Schulze-Lohoff E. (1998) Activation of purinergic P2Y2 receptors inhibits inducible NO synthase in cultured rat mesangial cells. Am. J. Physiol. 275(1), F103-F110.
Yamakuni H., Kawaguchi N., Ohtani Y., et al. (2002) ATP induces leukemia inhibitory factor mRNA in cultured rat astrocytes. J. Neuroimmunol. 129(1–2), 43–50.
Hou M., Moller S., Edvisson L., and Erlinge D. (2000) Cytokines induce upregulation of vascular P2Y2 receptors and increased mitogenic responses to UTP and ATP. Arterioscler. Thromb. Vasc. Biol. 20(9), 2064–2069.
Hou M., Moller S., Edvinsson L., and Erlinge D. (1999) MAPKK-dependent growth factor-induced upregulation of P2Y2 receptors in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 258(3), 648–652.
Marrelli S.P., Khorovets A., Johnson T.D., Childres W.F., and Bryan R.M., Jr. (1999) P2 purinoceptor-mediated dilations in the rat middle cerebral artery after ischemia-reperfusion. Am. J. Physiol. 276(1), H33-H41.
Kannan S. (2003) Neutrophil chemotaxis: potential role of chemokine receptors in extracellular nucleotide induced Mac-1 expression. Med. Hypotheses 61(5,6), 577–579.
Turner J.T., Park M., Camden J.M., and Weisman G.A. (1998) Salivary gland nucleotide receptors. Changes in expression and activity related to development and tissue damage. Ann. NY Acad. Sci. 842, 70–75.
Dennis E.A. (1994) Diversity of group types, regulation, and function of phospholipase A2. J. Biol. Chem. 269(18), 13,057–13,060.
Balsinde J., Winstead M.V., and Dennis E.A. (2002) Phospholipase A2 regulation of arachidonic acid mobilization. FEBS Lett. 531(1), 2–6.
Martin K.A., Kertesy S.B., and Dubyak G.R. (1997) Down-regulation of P2U-purinergic nucleotide receptor messenger RNA expression during in vitro differentiation of human myeloid leukocytes by phorbol esters or inflammatory activators. Mol. Pharmacol. 51(1), 97–108.
Gendron F.P., Chalimoniuk M., Strosznajder J., et al. (2003) P2X7 nucleotide receptor activation enhances IFNγ-induced type II nitric oxide synthase activity in BV-2 microglial cells. J. Neurochem. 87(2), 344–352.
Kopp S. (2001) Neuroendocrine, immune, and local responses related to temporomandibular disorders. J. Orofac. Pain 15(1), 9–28.
Vancheri C., Mastruzzo C., Sortino M.A., and Crimi N. (2004) The lung as a privileged site for the beneficial actions of PGE2. Trends Immunol. 25(1), 40–46.
Karaki S.I. and Kuwahara A. (2004) Regulation of intestinal secretion involved in the interaction between neurotransmitters and prostaglandin E2. Neurogastroenterol. Motil. 1, 96–99.
Ferreira S.H., Moncada S., and Vane J.R. (1997) Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. 1973. Br. J. Pharmacol. 120(4 Suppl.), 401–412; discussion 399–400.
Erb L., Liu J., Ockerhausen J., et al. (2001) An RGD sequence in the P2Y2 receptor interacts with αvβ3 integrins and is required for Go-mediated signal transduction. J. Cell Biol. 153(3), 491–501.
Li J.M., Fan L.M., Shah A., and Brooks G. (2003) Targeting αvβ3 and α5β1 for gene delivery to proliferating VSMCs: synergistic effect of TGF-β1. Am. J. Physiol. Heart Circ. Physiol. 285, H1123-H1131.
Hutchings H., Ortega N., and Plouet J. (2003) Extracellular matrix-bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation. FASEB J. 17(11), 1520–1522.
Pidgeon G.P., Tang K., Cai Y.L., Piasentin E., and Honn K.V. (2003) Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing αvβ3 and αvβ5 integrin expression. Cancer Res. 63(14), 4258–4267.
Zhang H., Li Z., Viklund E.K., and Stromblad S. (2002) P21-activated kinase 4 interacts with integrin αvβ5 and regulates αvβ5-mediated cell migration. J. Cell Biol. 158, 1287–1297.
Greig A.V., Linge C., Terenghi G., Mcgrouther D.A., and Burnstock G. (2003) Purinergic receptors are part of functional signaling system for proliferation and differentiation of human epidermal keratinocytes. J. Invest. Dermatol. 120(6), 1007–1015.
Schafer R., Sedehizade F., Welte T., and Reiser G. (2003) ATP- and UTP-activated P2Y receptors differently regulate proliferation of human lung epithelial tumor cells. Am. J. Physiol. Lung Cell. Mol Physiol. 285(2), L376-L385.
Wilden P.A., Agazie Y.M., Kaufman R., and Halenda S.P. (1998) ATP-stimulated smooth muscle cell proliferation requires independent ERK and PI3K signaling pathways. Am. J. Physiol. 275(4,) H1209-H1215.
Gungabissoon R.A. and Bamburg J.R. (2003) Regulation of growth cone actin dynamics by ADF/cofilin. J. Histochem. Cytochem. 51(4), 411–420.
Lin T., Zeng L., Liu Y., et al. (2003) Rho-ROCK-LIMK-cofilin pathway regulates shear stress activation of sterol regulatory element binding proteins. Circ. Res. 92(12), 1296–1304.
Rodgers E.E. and Theibert A.B. (2002) Functions of PI 3-kinase in development of the nervous system. Int. J. Dev. Neurosci. 20(3–5), 187–197.
Chan-Ling T. and Stone J. (1991) Factors determining the migration of astrocytes into the developing retina: migration does not depend on intact axons or patent vessels. J. Comp. Neurol. 303(3), 375–386.
Ellison J.A., Velier J.J., Spera P., et al. (1998) Osteopontin and its integrin receptor αvβ3 are upregulated during formation of the glial scar after focal stroke. Stroke 29(8), 1698–1706; discussion 1707.
Cao W., Luttrell L.M., Medvedev A.V., et al. (2000) Direct binding of activated c-Src to the beta 3-adrenergic receptor is required for MAP kinase activation. J. Biol. Chem. 275(49), 38,131–38,134.
Green S.A. and Liggett S.B. (1994) A prolinerich region of the third intracellular loop imparts phenotypic beta 1-versus beta 2-adrenergic receptor coupling and sequestration. J. Biol. Chem. 269(42), 26,215–26,219.
Tang Y., Hu L.A., Miller W.E., et al. (1999) Identification of the endophilins (SH3p4/p8/p13) as novel binding partners for the beta1-adrenergic receptor. Proc. Natl. Acad. Sci. USA 96(22), 12,559–12,564.
Oldenhof J., Vickery R., Anafi M., et al. (1998) SH3 binding domains in the dopamine D4 receptor. Biochemistry 37(45), 15,726–15,736.
Luttrell L.M., Della Rocca G.J., Van Biesen T., Luttrell D.K., and Lefkowitz R.J. (1997) Gβγ subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J. Biol. Chem. 272(7), 4637–4644.
Andreev J., Galisteo M.L., Kranenburg O., et al. (2001) Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade. J. Biol. Chem. 276(23), 20,130–20,135.
Soltoff S.P. (1998) Related adhesion focal tyrosine kinase and the epidermal growth factor receptor mediate the stimulation of mitogenactivated protein kinase by the G-protein-coupled P2Y2 receptor. Phorbol ester or [Ca2+]i elevation can substitute for receptor activation. J. Biol. Chem. 273, 23,110–23,117.
Soltoff S.P., Avraham H., Avraham S., and Cantley L.C. (1998) Activation of P2Y2 receptors by UTP and ATP stimulates mitogen-activated kinase activity through a pathway that involves related adhesion focal tyrosine kinase and protein kinase C. J. Biol. Chem. 273(5), 2653–2660.
Liu J., Liao Z., Camden J., et al. (2004) Src homology 3 binding sites in the P2Y2 nucleotide receptor interact with Src and regulate activities of Src, proline-rich tyrosine kinase 2, and growth factor receptors. J. Biol. Chem. 279(9), 8212–8218.
Avraham H., Park S.Y., Schinkmann K., and Avraham S. (2000) RAFTK/Pyk2-mediated cellular signalling. Cell Signal. 12(3), 123–133.
Du Q.S., Ren X.R., Xie Y., Wang Q., Mei L., and Xiong W.C. (2001) Inhibition of PYK2-induced actin cytoskeleton reorganization, PYK2 autophosphorylation and focal adhesion targeting by FAK. J. Cell Sci. 114(16), 2977–2987.
Lim I.J., Phan T.T., Tan E.K., et al. (2003) Synchronous activation of ERK and phosphatidylinositol 3-kinase pathways is required for collagen and extracellular matrix production in keloids. J. Biol. Chem. 278(42), 40,851–40,858.
Menu E., Kooijman R., Van Valckenborgh E., et al. (2004) Specific roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model. Br. J. Cancer 90(5), 1076–1083.
Ding X.Z., Tong W.G., and Adrian T.E. (2003) Multiple signal pathways are involved in the mitogenic effect of 5(S)-HETE in human pancreatic cancer. Oncology 65(4), 285–294.
Schafer M., Schafer C., Ewald N., Piper H.M., and Noll T. (2003) Role of redox signaling in the autonomous proliferative response of endothelial cells to hypoxia. Circ. Res. 92(9), 1010–1015.
Johnson G.L. and Lapadat R. (2002) Mitogenactivated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911–1912.
Daub H., Wallasch C., Lankenau A., Herrlich A., and Ullrich A. (1997) Signal characteristics of G protein-transactivated EGF receptor. EMBO J. 16(23), 7032–7044.
Qiao M., Shapiro P., Kumar R., and Passaniti A. (2004) Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a PI3K/ERK-dependent and Akt-independent signaling pathway. J. Biol. Chem. [E-pub ahead of press].
Okkenhaug K. and Vanhaesebroeck B. (2003) PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 3(4), 317–330.
Neary J.T., Kang Y., Bu Y., Yu E., Akong K., and Peters C.M. (1999) Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes: involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the phosphatidylinositol-specific phospholipase C/calcium pathway. J. Neurosci. 19(11), 4211–4220.
Neary J.T., Zhu Q., Kang Y., and Dash P.K. (1996) Extracellular ATP induces formation of AP-1 complexes in astrocytes via P2 purinoceptors. Neuroreport 7(18), 2893–2896.
Neary J.T., McCarthy M., Cornell-Bell A., and Kang Y. (1999) Trophic signaling pathways activated by purinergic receptors in rat and human astroglia. Prog. Brain Res. 120, 323–332.
Santiago-Perez L.I., Flores R.V., Santos-Berrios C., et al. (2001) P2Y2 nucleotide receptor signaling in human monocytic cells: activation, desensitization and coupling to mitogen-activated protein kinases. J. Cell Physiol. 187(2), 196–208.
Gendron F.P., Neary J.T., Theiss P.M., Sun G.Y., Gonzalez F.A., and Weisman G.A. (2003) Mechanisms of P2X7 receptor-mediated ERK1/2 phosphorylation in human astrocytoma cells. Am. J. Physiol. Cell Physiol. 284(2), C571-C581.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weisman, G.A., Wang, M., Kong, Q. et al. Molecular determinants of P2Y2 nucleotide receptor function. Mol Neurobiol 31, 169–183 (2005). https://doi.org/10.1385/MN:31:1-3:169
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/MN:31:1-3:169